monoclonal antibody

Related by string. Monoclonal Antibody * Monoclonal : therapeutic monoclonal antibodies / Antibody : antibody mediated rejection * human monoclonal antibody . humanized monoclonal antibody . Crucell rabies monoclonal antibody . monoclonal antibody Rituxan . anthrax monoclonal antibody . monoclonal antibody therapeutics . monoclonal antibody therapies . CD# monoclonal antibody *

Related by context. All words. (Click for frequent words.) 79 antibody 75 monoclonal antibodies 71 humanized antibody 71 human monoclonal antibody 70 humanized monoclonal antibody 67 synthetic peptide 67 immunotherapeutic 67 antibody fragment 67 therapeutic antibodies 67 therapeutic antibody 66 mAb 66 humanized monoclonal antibodies 66 fusion proteins 66 small molecule 66 monoclonal antibody mAb 66 monoclonal 65 anti CD# antibody 65 chimeric monoclonal antibody 65 immunotherapy 65 Nanobody 65 antibodies 65 recombinant protein 65 novel peptide 64 peptide 64 humanized anti 64 Factor VIIa 64 mertansine 64 humanized antibodies 64 prophylactic vaccine 63 immunomodulator 63 peptide antigens 63 immunotoxin 63 therapeutic monoclonal antibodies 63 siRNA therapeutic 63 oral antiviral 63 investigational humanized monoclonal antibody 63 milatuzumab 63 humanized monoclonal 63 alpha interferon 63 drug conjugate 63 oncolytic viruses 63 polyclonal antibody 63 CTLA 4 63 MAb 63 chemically modified siRNA 63 M2 subunit 63 oncolytic 63 TLR9 agonist 63 tyrosine kinase inhibitor 63 mAbs 63 targeted radiotherapeutic 63 OncoVEX 63 proteasome inhibitor 63 angiogenesis inhibitor 63 recombinant adeno associated 63 siRNA 63 IgG1 antibody 63 bioactive lipids 63 Tarvacin TM 62 PI3K inhibitor 62 antisense drug 62 bispecific antibody 62 fusion protein 62 small molecule inhibitors 62 targeted antifolate 62 BiTE 62 dendritic cell 62 CD# antibody [001] 62 HER2/neu 62 AAV vector 62 epothilone 62 lentiviral vector 62 therapeutics 62 CYC# 62 oncolytic virus 62 VEGF receptor 62 proteasome inhibitors 62 vaccine adjuvant 62 IRX 2 62 MT#/MEDI-# 62 anti CD3 62 GM CSF 62 therapeutic monoclonal antibody 61 Anticalins R 61 kinase inhibitor 61 Zolinza 61 orally bioavailable 61 Tarvacin 61 nanoviricide 61 CCX# 61 JAK inhibitor 61 VitiGam 61 polyclonal 61 Proxinium TM 61 monoclonal antibodies mAbs 61 polymerase inhibitor 61 recombinant antibodies 61 humanised monoclonal antibody 61 bispecific 61 OncoVEX GM CSF 61 immunotherapeutics 61 HuMax CD# 61 PEGylated 61 Sphingomab 61 small molecule inhibitor 61 Nanobody ® 61 cytotoxic 61 molecularly targeted 61 CD# [002] 61 Anticalin R 61 A3 adenosine receptor 61 investigational monoclonal antibody 61 adenoviral 61 IMA# 61 XmAb# 61 preclinical 61 MEK inhibitor 61 poly ADP ribose polymerase 61 immune modulatory 61 CD# monoclonal antibody 61 adenovector 61 anti CD# monoclonal 61 Onconase 61 aptamer 60 recombinant 60 chemotherapeutic drug 60 RNAi therapeutic 60 JAK3 60 Nanobodies 60 recombinant human 60 nanoviricides 60 Pertuzumab 60 TLR8 60 IAP inhibitors 60 oral prodrug 60 MAbs 60 pegylated 60 Pradefovir 60 antibody MAb 60 anticancer therapies 60 cancer immunotherapy 60 investigational antibody 60 MVA BN R 60 virotherapy 60 cancer immunotherapies 60 Interferon alpha 60 AEG# 60 Radilex 60 preclinical studies 60 MVA BN 60 selective kinase inhibitor 60 polyclonal antibodies 60 PEG SN# 60 recombinant subunit vaccine 60 anticancer agent 60 PARP inhibitor 60 HepDirect prodrug 60 monoclonal antibodies MAbs 60 MAXY G# 60 PORxin TM 60 Bavituximab 60 HCV protease inhibitor 60 HDAC inhibitor 60 PSMA ADC 60 immunomodulators 60 prodrugs 60 huC# DM4 60 PDE4 inhibitor 60 neuraminidase inhibitor 60 cancer therapeutics 60 BiTE antibody 60 histone deacetylase HDAC inhibitor 60 ESBA# 60 Aflibercept 60 multi kinase inhibitor 60 interferon alpha 60 thymalfasin 60 enzyme inhibitor 60 antitumoral 60 antisense oligonucleotide 60 MMAE 60 OMP #M# 59 immunostimulatory 59 anticancer therapeutics 59 immune modulators 59 DepoVax 59 prodrug 59 somatostatin analogue 59 Sym# 59 NEUGENE 59 FLT3 59 anti CD3 monoclonal 59 peptides 59 investigational immunotherapy 59 histone deacetylase HDAC 59 histone deacetylase inhibitor 59 polymerase inhibitors 59 EGF receptor 59 T DM1 59 HuLuc# 59 HER2 receptor 59 targeting CD# 59 biologic therapies 59 chemotherapeutic agent 59 TG# [001] 59 selective inhibition 59 Panzem 59 histone deacetylase inhibitors 59 molecular chaperone 59 CEQ# 59 5 HT4 receptor 59 radiolabeled monoclonal antibody 59 virosome 59 chemotherapy induced neutropenia 59 Daclizumab 59 DOS# 59 adenovirus vector 59 JAK1 59 antitumor 59 immune modulation 59 PARP inhibitors 59 Litx 59 ISF# 59 ZFP TF 59 anti angiogenic 59 HuCAL antibody 59 Olaparib 59 Ceflatonin 59 intratumoral injection 59 monoclonal antibody MAb 59 depsipeptide 59 EGFr 59 HSP# inhibitor 59 NTDDS 59 fluoropyrimidine 59 VEGF Trap 59 tumor antigen 59 PEGylated interferon 59 Locked Nucleic Acid LNA 59 Dapagliflozin 59 anti CD3 antibody 59 BiTE ® 59 Micromet BiTE 59 MEK inhibitors 59 RhuDex ® 59 fusion inhibitor 59 antisense 59 IGF 1R 59 mapatumumab 59 cleavable linker 59 RNAi therapeutic targeting 59 EpCAM 59 nicotinic acetylcholine receptor 59 PI3K inhibitors 59 YONDELIS 59 ALN TTR 59 BiovaxID 59 HCD# [002] 59 ENMD # 59 Aurora kinase inhibitor 59 Alfacell proprietary ribonuclease 59 bortezomib Velcade 59 liposomal 59 novel peptides 59 replicon 59 CD# antibodies 59 novel immunotherapeutic 59 TLR9 agonists 59 TRAIL receptor 59 murine monoclonal antibody 59 Fc fusion protein 58 epothilones 58 GRNVAC1 58 synthetic retinoid 58 Archexin 58 Hsp# inhibitor 58 IAP inhibitor 58 PEGylated Fab fragment 58 mitogen activated ERK kinase 58 Homspera 58 peptibody 58 Sphingomab TM 58 OncoVex 58 Monoclonal antibodies 58 microtubule inhibitor 58 IgG1 monoclonal antibody 58 anticancer agents 58 pharmacological chaperone 58 EGFR HER 58 EGFRvIII 58 DepoVax TM 58 Anticalins ® 58 anti EGFR antibody 58 GV# [001] 58 Gleevec resistant 58 Ontak 58 interferon beta 58 luteinizing hormone releasing 58 ALN TTR# 58 recombinant fusion 58 DermaVir 58 personalized immunotherapy 58 anticancer therapy 58 Scancell 58 glioblastoma multiforme GBM 58 neutralizing antibody 58 IMC #B 58 novel anticancer 58 CYT# 58 erlotinib Tarceva ® 58 PEG Interferon lambda 58 mTOR inhibitor 58 eniluracil 58 IMC A# 58 delta isoform 58 Janus Kinase 58 potently inhibit 58 Vidofludimus 58 Pralatrexate 58 lentiviral 58 Erbitux cetuximab 58 DXL# 58 short interfering RNA 58 antisense drugs 58 anti angiogenic agent 58 FGFR 58 pertuzumab 58 kinase inhibitors 58 Th2 cytokines 58 PLX# 58 virus AAV 58 pDCs 58 vascular disrupting agents 58 Epratuzumab 58 immunotherapeutic agent 58 TNFa 58 selective orally bioavailable 58 interleukin IL -# 58 plasmid DNA vaccine 58 cytotoxin 58 selective agonist 58 EZN 58 antigen 58 HepDirect 58 anticancer compounds 58 anti CD# antibodies 58 PKC# 58 Ofatumumab 58 IGF IR 58 antigen CD# 58 siRNA therapeutics 58 BCR ABL inhibitors 58 immunotherapies 58 myelofibrosis polycythemia vera 58 orally administered inhibitor 58 ErbB3 58 deacetylase inhibitors 58 cilengitide 58 Nexavar ® 58 chimeric antibodies 58 PSMA antibody 58 immunomodulatory 58 IL #R 58 HER2 antibody 58 paclitaxel Taxol 58 agonistic human 58 histone deacetylase HDAC inhibitors 58 tyrosine kinase receptor 58 MORAb 58 siRNA delivery 58 PER.C6 ® 58 Carfilzomib 58 liposomal formulation 58 LEX System 58 biologic therapeutics 58 Ampligen R 58 TG# [003] 58 monoclonal anti 58 HGS ETR1 58 MyVax R 58 selective inhibitor 58 murine mouse 58 CXCR4 receptor 58 TLR7 58 glioma cells 58 vidofludimus 58 PI3K/mTOR 58 antisense inhibitor 58 TNFα 58 Antibody 57 factor G CSF 57 HuMax CD4 57 Omacetaxine 57 CDDO Im 57 pan HDAC inhibitor 57 ATL# [001] 57 PNP inhibitor 57 Talabostat 57 Rituximab 57 MUC1 57 busulfan 57 SERMs 57 HyperAcute 57 NPC 1C 57 Angiocept 57 Micromet proprietary BiTE 57 ribonucleotide reductase clinically validated 57 bavituximab 57 antigens 57 protein kinase inhibitor 57 T#I [002] 57 Debio 57 TREANDA 57 allogeneic cell 57 Vascular Endothelial Growth 57 Anidulafungin 57 multitargeted 57 AtuRNAi 57 immune modulator 57 hypoxia inducible factor 57 Bezielle 57 Vicinium TM 57 selective antagonist 57 Hedgehog pathway 57 interferons 57 isoform selective 57 photosensitizer 57 selectively inhibit 57 Enzastaurin 57 survivin 57 NexACT 57 Epidermal Growth Factor Receptor 57 peptidomimetic 57 phage display 57 soluble tumor necrosis 57 Vitaxin 57 DNA plasmids 57 anti phosphatidylserine 57 CTLA4 Ig 57 rituximab Rituxan 57 Homspera TM 57 tumor specific antigen 57 kallikrein 57 Ixabepilone 57 Azedra 57 topical anti infective 57 DermaVir Patch 57 Golimumab 57 potent inhibitor 57 vascular disrupting agent 57 thrombin receptor 57 Monoclonal Antibody 57 BAY #-# 57 recombinant vaccine 57 SynCon ™ DNA 57 multiple myeloma MM 57 Goserelin 57 Erlotinib 57 DiLA2 57 dacetuzumab 57 Hycamtin 57 lentiviral vectors 57 tubulin binding 57 #ME# 57 gamma secretase inhibitors 57 sodium glucose cotransporter 57 systemic RNAi therapeutic 57 HER3 57 otelixizumab 57 pomalidomide 57 activated lymphocytes 57 anticancer 57 disease modifying 57 aptamers 57 small molecule agonists 57 ADP receptor antagonist 57 Azixa 57 Amrubicin 57 XL# inhibits 57 IMGN# 57 EndoTAG TM -1 57 Traficet EN 57 rxRNA 57 transfection reagent 57 Th# 57 nanoemulsion 57 anti TNF alpha 57 CCR2 57 effector function 57 EndoTAG 57 BAL# [001] 57 receptor tyrosine kinase inhibitor 57 DermaPrep 57 AVP #D# 57 Ganciclovir 57 Aviptadil 57 Luteinizing Hormone Releasing Hormone 57 Bortezomib 57 sphingosine 1 57 HCV protease 57 immune stimulatory 57 AVI NEUGENE 57 attenuated strain 57 IgG1 57 vinca alkaloid 57 HDAC 57 Onalta 57 taxane 57 herpes simplex viruses 57 Rituxan rituximab 57 Valortim R 57 MyVax 57 recombinant polyclonal antibody 57 protein kinase inhibitors 57 dAbs 57 TRX1 57 CBLC# 57 phosphatidylserine PS targeting 57 Cyclosert 57 INGN 57 chemokine 57 ActA 57 TKM ApoB 57 xenograft models 57 CDK inhibitor 57 G CSF 57 Oral NKTR 57 oncolytic vaccine 57 radiation sensitizer 57 novel antibody therapeutics 57 Zybrestat 57 engineered RAP peptides 57 TRAIL R2 57 topical ophthalmic 57 H#N# VLP vaccine 57 Elvitegravir 57 rhIL 7 57 Irinotecan 57 protein tyrosine phosphatase 1B 57 Genentech Herceptin 57 investigational drug 57 Vorinostat 57 LNP formulations 57 dependent cellular cytotoxicity 57 induce apoptosis 57 exon skipping 57 EGFR 57 brostallicin 57 butyrylcholinesterase 56 nanoparticle formulation 56 oligonucleotide 56 oncolytic virus therapy 56 Angiolix 56 Chemokine Receptor 56 oxidative stress inducer 56 docetaxel Taxotere ® 56 REP# 56 bispecific antibodies 56 flavopiridol 56 ketolide antibiotic 56 bleomycin 56 antiviral compounds 56 taxol 56 peptidic compound 56 JAK inhibitors 56 Oncaspar 56 TLR8 agonist 56 potent cytotoxic 56 tolerogenic 56 obatoclax 56 Monoclonal antibody 56 cellular immunotherapy 56 NS4A 56 Preclinical studies suggest 56 mTOR mammalian target 56 HQK 56 Degarelix 56 ANG# 56 biologic therapy 56 JAK2 inhibitor 56 cyclin dependent kinase inhibitor 56 lipid nanoparticle 56 GRN#L 56 nucleoside analog 56 anti infective treatments 56 antisense compounds 56 HGS ETR2 56 scFv 56 SynCon TM DNA 56 Tumor Necrosis Factor 56 #D#C# 56 Maribavir 56 Phenoxodiol 56 selective modulator 56 ABRAXANE ® 56 vorinostat 56 enveloped viruses 56 cytotoxic T lymphocyte 56 Leukine ® 56 VEGF receptor inhibitor 56 LymphoStat B belimumab 56 Octreotide 56 biotherapeutics 56 elotuzumab 56 receptor antagonists 56 meropenem 56 antiproliferative effects 56 LHRH 56 prophylactic vaccines 56 cytostatic 56 SAR# [002] 56 HepaGam B 56 alkylating agent 56 IgG antibodies 56 Oligonucleotide 56 antisense oligonucleotides 56 Cytolin ® 56 HGS# 56 AMPK activators 56 beta lactamase inhibitor 56 murine 56 taxane derivative 56 ImmunoGen TAP technology 56 CD# molecule 56 small molecule glucokinase 56 DepoVax ™ 56 Trastuzumab 56 GelSite R polymer 56 AAV2 56 BiTE R 56 antifungal agent 56 Vaxfectin TM adjuvant 56 Dalbavancin 56 ASONEP 56 amphotericin B 56 PLX cells 56 NY ESO 56 AGS PSCA 56 FluCide 56 flu mAb 56 humanised antibody 56 DNA plasmid 56 transfection reagents 56 generation antisense 56 CD# antigen 56 Hsp# inhibitors 56 VLP vaccine 56 NFkB 56 GW# [003] 56 AP# [003] 56 VEGF 56 GPR# agonist 56 XL# XL# 56 anticancer compound 56 OvaRex R 56 Gefitinib 56 GeoVax vaccine 56 thrombopoietin 56 lumiliximab 56 siRNAs 56 cetuximab Erbitux ® 56 Cytotoxic T 56 BZL# 56 oncolytic virus therapies 56 investigational therapies 56 CD#L 56 inhibit EGFR 56 inhibitor 56 OXi# 56 BRAF inhibitors 56 EndoTAG TM 56 intradermal injection 56 inverse agonist 56 Enkephalin 56 P#X# 56 Methylnaltrexone 56 tumorigenic 56 Virulizin ® 56 Tß4 56 rituximab 56 radionuclide therapy 56 agonist compounds 56 IFN alpha 56 colon carcinoma 56 small molecule tyrosine 56 BCR ABL 56 volociximab 56 mediate antibody 56 entinostat 56 prostacyclin receptor 56 synthetic peptides 56 aT cell 56 UsiRNAs 56 stable nucleic acid 56 methylnaltrexone 56 NEUGENE antisense 56 stable linker 56 Blinatumomab 56 fluoroquinolone antibiotic 56 Xencor XmAb 56 POTELLIGENT ® 56 HCV polymerase 56 AKT inhibitor 56 XmAb ® 56 Mipomersen 56 inhibit VEGF 56 Panzem R 56 autologous cellular immunotherapy 56 novel immunotherapies 56 OxBC 56 CA4P 56 Protexia R 56 HCV protease inhibitors 56 OHR/AVR# 56 CD4 monoclonal antibody 56 Panitumumab 56 Anticalin 56 INS# [001] 56 cytoprotective 56 Viprovex TM 56 L asparaginase 56 nanoviricide drug 56 small molecule thrombopoietin 56 biotherapeutic 56 EphA2 56 interferon 56 synthetic siRNA 56 rxRNA ™ compounds 56 peripherally acting 56 Genentech Rituxan 56 Anticalin ® 56 hTERT 56 Ixempra 56 C5a 56 PRT# 56 transient receptor 56 selective androgen receptor modulators 56 gastrin 56 GPNMB 56 FAAH 56 tumor antigens 56 gallium containing 56 Carboplatin 56 accumulate preferentially 56 HspE7 56 Lpathomab 56 AdVac ® 56 C5aR 56 cancer vaccine Norelin 56 PDGF receptor 56 CTCE 56 Aurora kinase 56 echinocandins 56 Medarex UltiMAb R 56 Aplidin 56 Tesetaxel 56 histone deacetylase 56 LNPs 56 alpha folate receptor 56 NeuroTrans TM 56 lipopeptide 56 allosteric modulators 56 ProMune 56 Alpharadin 56 MOR# 56 Temsirolimus 56 TheraCIM 56 Preclinical studies 56 ELND# 56 Imprime PGG 56 Onalta ™ 56 integrase inhibitor 56 viral vector 56 intravesical instillation 56 intravenously administered 56 CD3 monoclonal antibody 56 insulin sensitizer 56 potent antiproliferative 56 small interfering RNA 56 polysaccharide polymer 56 intranasal delivery 56 attach auristatin 56 PEGPH# 56 mu opioid receptor antagonist 56 Transdrug ® nanoparticle 56 MAGE A3 ASCI 56 maturation inhibitor 56 prostate cancer antigen prostatic 56 MAGE A3 56 HuMax EGFr 56 systemically administered 56 pradefovir 56 pro angiogenic 55 immune modulating 55 XmAb TM 55 SMaRT ™ 55 Bevacizumab 55 VEGF inhibitors 55 NF kB pathway 55 induces apoptosis 55 Pazopanib 55 MKC# MT 55 Hedgehog signaling pathway 55 Urocidin 55 Maxy G# 55 mouse xenograft models 55 Docetaxel 55 imatinib Gleevec ® 55 HDAC inhibition 55 orally dosed 55 nitric oxide donating 55 therapeutic proteins 55 Reolysin 55 isotype 55 HDACi 55 Exelixis compounds 55 ocular formulation 55 Multimeric 55 antibody MT# 55 Curaxin 55 ganciclovir 55 Antigenics QS 55 DAVANAT R 55 SAR# [004] 55 Elotuzumab 55 tkRNAi 55 THR beta agonist 55 pDNA vaccines 55 novel topoisomerase 55 CHO cells 55 triphendiol 55 RANK ligand 55 Fodosine 55 miR #a [002] 55 cytotoxic agents 55 chemokine receptor 55 HuMax TAC 55 monoclonals 55 Alferon N 55 Cethrin R 55 KNS # 55 MVA BN ® 55 Liposomal 55 Allovectin 7 R 55 immatics 55 sclerostin 55 fusion inhibitors 55 rNAPc2 55 Kahalalide F 55 preclinical models 55 Amigal 55 azoles 55 Elesclomol 55 vWF 55 immunoconjugate 55 GlycoPEG GCSF 55 BRAF inhibitor 55 liposomal doxorubicin 55 GLPG# 55 retinoic acid receptor 55 CCR5 inhibitor 55 Epothilones 55 carbohydrate polymer 55 Aptamer 55 intranasal formulation 55 auristatin 55 antibody fragments 55 investigational compound 55 Onco TCS 55 Pathway Inhibitor 55 Xanafide 55 protective antigen 55 HER1 55 Payload TAP technology 55 highly selective endothelin 55 thymidylate synthase TS 55 bortezomib Velcade ® 55 lentivirus 55 interferon lambda 55 siRNA compounds 55 geldanamycin 55 thymosin beta 4 55 RNA antagonist 55 Valortim 55 FK# 55 alpha#beta# integrin 55 Prednisporin 55 Aptivus ® 55 radiotherapeutic 55 GM CSF granulocyte 55 active cellular immunotherapy 55 Intravenous Human 55 hedgehog pathway 55 docetaxel Taxotere R 55 AAV vectors 55 Lixivaptan 55 Davanat 55 E#F# 55 telomerase reverse transcriptase 55 signal transduction inhibitor 55 using Crucell PER.C6 55 lexidronam injection 55 HSP# inhibitors 55 Symadex 55 dexpramipexole 55 glycosylated 55 potently inhibited 55 CCR1 55 renin inhibitors 55 Factor VEGF 55 adeno associated virus 55 CCR9 55 topical lotion 55 XmAb 55 Sudhir Agrawal D.Phil 55 DHFR 55 CXCR4 55 novel immunomodulatory 55 adecatumumab 55 Lenalidomide 55 NeuroVax TM 55 novel histone deacetylase 55 c MET 55 KB# [004] 55 IMiDs R 55 adenoviral vector 55 potent topoisomerase II 55 PTH analogue 55 NP2 55 receptor CXCR4 55 Exherin TM 55 Vaxfectin 55 indibulin 55 daptomycin 55 Nimotuzumab 55 orthotopic model 55 bortezomib 55 Aptocine 55 anti CTLA 55 TTR gene 55 Crizotinib 55 PSN# [002] 55 RAF kinase 55 trabectedin 55 veltuzumab 55 inhibit viral replication 55 Personalized Immunotherapy 55 potent anticancer 55 Virulizin R 55 monoclonal antibody therapeutics 55 Thiovir 55 telomerase therapeutic 55 CCR5 antagonist 55 elacytarabine 55 Trp p8 55 immunosuppressant 55 PD LID 55 Pancreate 55 neutralizing antibodies 55 PROCHYMAL 55 Shigamabs ® 55 CD# receptor 55 plasma proteins 55 antibody therapies 55 cidofovir 55 immunotoxins 55 HDAC inhibitors 55 PEP# [003] 55 soluble receptor 55 Belerofon 55 2DG 55 camptothecin 55 oral JAK1 55 Crofelemer 55 deacetylase 55 Factor Xa inhibitor 55 imatinib Gleevec 55 Milatuzumab 55 selective inverse agonist 55 shRNA 55 Ocrelizumab 55 Factor Receptor 55 immunological diseases 55 Apo2L 55 nucleoside reverse transcriptase inhibitor 55 metastatic colorectal 55 LEAPS TM 55 Chrysalin 55 Aganocide 55 REMUNE R 55 selective androgen receptor modulator 55 Hsp# Inhibitor 55 metaglidasen 55 Boceprevir 55 myeloma cells 55 Ii protein 55 selective adenosine 55 ALK inhibitor 55 anti TNF

Back to home page